URES of acute and chronic leukaemias, as seen in various parts of the African Continent, have been previously extensively described (Allan & WatsonWilliams, 1963; Kasili & Taylor, 1970; Lothe, 1967; Essien, 1972; Fleming, 1977 , Fleming, 1979 . These reports not only indicated the rarity of acute lymphoblastic leukaemia (ALL) in early years of life, but also the higher occurrence of acute myelogenous leukaemia (AML) in childhood. A number of other reports have also described the frequent occurrence of chloromas in association with acute leukaemia (AL) in African children (Barsoum, 1938; Davies & Owor, 1965) . The present report seeks in particular to compare and contrast the clinical features of childhood AL as seen in the children of Ibadan, Nigeria, and their Caucasian counterparts in the developed Western countries.
PATIENTS AND METHODS
All patients included in this report were indigenous Nigerian residents in the tropical rain-forest belt of the country. Most of the patients resided in Ibadan, a city of about 1 million people. Some of the patients lived in smaller neighbouring towns and villages. The parents of most of the children were illiterate peasant farmers or petty traders.
The patients were referred to the Univers- Hayhoe & Cawley (1972) and Bennett et al. (1976) . Lymphocyte surface purine (100 mg/m2/day orally) and methotrexate (12-5 mg/M2 orally twice weekly). At 3-monthly intervals, consolidation chemotherapy was given as i.v. Adriamycin (20 mg/ m2/day x 3), i.v. vincrinstine (2-0 mg/M2 on Days 1 and 8) and oral prednisolone (40 mg/m2/day for 14 days). Patients receiving the treatment regimen as described were considered "adequately treated". Others who for various reasons deviated significantly from the regimen were considered "'inadequately treated". No patient received cranial irradiation.
The treatment of AML w-as much less organized and on the whole unsatisfactory. mainly because of the sporadic availability of the necessary drugs and difficulty in providing haematological supportive care as well as appropriate antibiotic coverage.
RESULTS
Of the 51 newly diagnosed cases of acute leukaemia seen in the period July 1978 to December 1981 at the U.C.H., Ibadan, Nigeria, 29 (58%) occurred in children (i.e. < 14 years old). The cytological classification of the cases is shown in Table I . Seventy-six per cent of all cases of ALL and 39O% of all cases of AML occurred in children. Childhood ALL was of "Null"-cell type in 3, and T-cell type in 2 out of 5 cases investigated appropriately. These and other clinical and laboratory features in our ALL patients are shown in Table II . The male: female ratio was 2 8: 1 and 4 5: ] for childhood ALL and AML respectively. The incidence of ALL and AML for all childhood ages was about the same (i.e. 0*8 x 10-5) for the city of Ibadan. AML occurred most frequent among boys of the age group 5-9 years, while the incidence of ALL was highest among boys of the age group 10-14 years. A comparison of the incidence of childhood AL in Ibadan with reported data from some developed countries (Table III) showed that the marked peak incidence of ALL in the first 4 years of life in the U.S. White and Black children was not found in Ibadan. Furthermore, the relatively high incidence of AML in Ibadan children between the ages of 5 and 9 has not been reported recently in any Western Caucasian population. Similarly, the high frequency of chloromas in Ibadan children in association with AML (6/11 (54%) for ages 0-14, and 62% for ages 5-9) stands in sharp contrast to reported data from Western Caucasian populations (Table III) . These chloromas occurred in the ocular orbits in 3, oropharynx in 2, meninges in 1 and the genitourinary tract in 1 patient.
As shown in Table II , PCV in 10/15 children fell within the intermediate range of 15-30% ('%5-10g/dl) and 11-14% in the remaining 5. Hyperleucocytosis occurred in all but one child with a WBC count < 1010/1 (Patient 16). Hepatosplenomegaly of varying degrees was seen in 12 ALL patients, including Patient 6 with a normal WBC count. However, invasion of the CNS, mediastinum, testes and kidneys occurred only in association with marked leucocytosis (WBC>1012/1) with the exception of Patient 9. LI, L2 and L3 cell morphology was observed in 2, 9 and 1 patient respectively. PAS was strongly positive ( 900%) in 3, weakly positive (2-20%) in 3, and negative in 6/12 patients in whom the test was done.
Nine of 13 cases of ALL (69%) and 4/8 cases of AML (50%) achieved various degrees of remission. Like all AML cases, the duration of remission in most of the ALL cases was short (62-160 days) regardless of whether the children were "adequately" treated. However, the results in 2 of the ALL patients (Table II as seen in Ibadan are contrasted with data published for Caucasian and Black American children in Table III . It appears that the low incidence of ALL in Ibadan children reflects a true deficit rather than under-diagnosis. This is indicated by the low ALL/Wilms' tumour ratio in Ibadan and the U.S. Black children, since the occurrence of Wilms' tumour is said to vary little throughout the world (Miller, 1972; Williams, 1975) . The low ALL/AML ratio in Ibadan children may also reflect the reduced incidence of ALL in the population (Table III) . Similarly, the marked male excess in ALL and AML is real and is at variance with the balanced sex ratio seen in Wilms' tumour (Williams, 1975) .
DISCUSSION
The demographic structure of the developing countries is characterized by a disproportionately large child population (Loraine, 1974 (Table  III) suggests a marked difference in disease manifestation. Similar frequent association of AML and chloroma has been reported from other parts of Africa (Davies & Owor, 1965) and Turkey (Cavdar et al., 1971 ) and a possible role has been suggested for the Epstein-Barr virus by Cavdar et al. (1973, unpublished) in the aetiology of chloroma-associated AML in Turkish children. It is interesting that in an ethnically pluralistic society like South Africa, the patterns of ALL and AML in Caucasian and Black children follows the trends outlined above (MacDougall & Janowitz, 1981, unpublished) , thus signifying an association between childhood AL and the life-style of the society.
The poor response to treatment of ALL in Ibadan children stands in sharp contrast to the results reported for children in developed countries (Simone et al., 1978) . The absence of radiotherapy in the treatment modality of our patients would not adequately explain these poor results, because treatment failure in our "adequately treated" patients resulted mainly from marrow relapse rather than CNS relapse. Although 11 of the 19 (58%) Ibadan children with ALL fell within the prognostically favourable age range of 2-7 years, it would appear that the common presence of other poor-risk factors, like marked leucocytosis (Jacquillat et al., 1973; Glidewell & Holland, 1973, unpublished) , L2 lymphoblast morphology (Miller et al., 1979) and absent or low PAS reaction of the lymphoblasts (Lilleyman et al., 1979; Palmer et al., 1980) (Table II) suggested that high PAS block positivity was an important positive risk factor. However, the poor outcome in Patient 16 would suggest that some yet unidentified prognostic factor could have 93 played an additional role among our patients.
From observations reported in this series, it would appear that the so-called "standard risk ALL" (i.e. ALL at 2-7 years of age with a WBC count < 1010/1 and a good response to chemotherapy) is a rare disease in our part of the world. As outlined in Tables II and III the clinical features of ALL and AML in Ibadan children are different from those reported for Caucasian children, and further investigation of these differences is required.
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